Literature DB >> 15469922

A function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen.

Margaret T Chen1, Jean-Noel Billaud, Matti Sällberg, Luca G Guidotti, Francis V Chisari, Joyce Jones, Janice Hughes, David R Milich.   

Abstract

A unique characteristic of the hepatitis B virus is the production of a secreted form (precore or HBeAg) of the structural nucleocapsid (core or HBcAg). By using T cell receptor (TCR) transgenic (Tg) and TCR x HBc/HBeAg double- and triple-Tg pairs, we demonstrate that HBeAg elicits T cell tolerance, whereas HBcAg is nontolerogenic in this system. In fact, TCR x HBc double-Tg mice spontaneously seroconvert to IgG anti-HBc positivity at an early age. However, the presence of HBeAg in the serum of TCR x HBc x HBe triple-Tg mice prevents anti-HBc seroconversion. HBeAg mediates its immunoregulatory effect by eliciting tolerance in HBc/HBeAg-specific T cells. The results suggest that hepadnaviruses have retained a secretory form of the nucleoprotein because it functions as a T cell tolerogen and regulates the immune response to the intracellular nucleocapsid. This HBeAg-mediated immune regulation may predispose to chronicity during perinatal infections and prevent severe liver injury during adult infections.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15469922      PMCID: PMC522042          DOI: 10.1073/pnas.0406282101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

Review 1.  T cell anergy.

Authors:  Ronald H Schwartz
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

2.  The hepatitis B virus core and e antigens elicit different Th cell subsets: antigen structure can affect Th cell phenotype.

Authors:  D R Milich; F Schödel; J L Hughes; J E Jones; D L Peterson
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

3.  The secreted hepatitis B precore antigen can modulate the immune response to the nucleocapsid: a mechanism for persistence.

Authors:  D R Milich; M K Chen; J L Hughes; J E Jones
Journal:  J Immunol       Date:  1998-02-15       Impact factor: 5.422

4.  Nondeletional T-cell receptor transgenic mice: model for the CD4(+) T-cell repertoire in chronic hepatitis B virus infection.

Authors:  M Chen; M Sällberg; S N Thung; J Hughes; J Jones; D R Milich
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

5.  Role of B cells in antigen presentation of the hepatitis B core.

Authors:  D R Milich; M Chen; F Schödel; D L Peterson; J E Jones; J L Hughes
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

6.  Precore stop mutant in HBeAg-positive patients with chronic hepatitis B: clinical characteristics and correlation with the course of HBeAg-to-anti-HBe seroconversion.

Authors:  Chia-Ming Chu; Chau-Ting Yeh; Ching-Song Lee; I-Shyan Sheen; Yun-Fan Liaw
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

7.  Influence of T-helper cell subsets and crossregulation in hepatitis B virus infection.

Authors:  D R Milich
Journal:  J Viral Hepat       Date:  1997       Impact factor: 3.728

8.  Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen.

Authors:  H Okamoto; F Tsuda; Y Akahane; Y Sugai; M Yoshiba; K Moriyama; T Tanaka; Y Miyakawa; M Mayumi
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

Review 9.  Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection.

Authors:  David Milich; T Jake Liang
Journal:  Hepatology       Date:  2003-11       Impact factor: 17.425

10.  Hepatitis B virus nucleocapsid particles do not cross the hepatocyte nuclear membrane in transgenic mice.

Authors:  L G Guidotti; V Martinez; Y T Loh; C E Rogler; F V Chisari
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

View more
  97 in total

1.  Identification of a unique double-negative regulatory T-cell population.

Authors:  Byung O Lee; Joyce E Jones; Cory J Peters; David Whitacre; Lars Frelin; Janice Hughes; Won-Keun Kim; David R Milich
Journal:  Immunology       Date:  2011-12       Impact factor: 7.397

2.  Assessing sequence plasticity of a virus-like nanoparticle by evolution toward a versatile scaffold for vaccines and drug delivery.

Authors:  Yuan Lu; Wei Chan; Benjamin Y Ko; Christopher C VanLang; James R Swartz
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-21       Impact factor: 11.205

Review 3.  Stealth and cunning: hepatitis B and hepatitis C viruses.

Authors:  Stefan F Wieland; Francis V Chisari
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

Review 4.  Update of research and management of hepatitis B.

Authors:  Takeshi Okanoue; Masahito Minami
Journal:  J Gastroenterol       Date:  2006-02       Impact factor: 7.527

5.  Transformation of hepatitis B serologic markers in babies born to hepatitis B surface antigen positive mothers.

Authors:  Jian-She Wang; Hui Chen; Qi-Rong Zhu
Journal:  World J Gastroenterol       Date:  2005-06-21       Impact factor: 5.742

6.  A high level of mutation tolerance in the multifunctional sequence encoding the RNA encapsidation signal of an avian hepatitis B virus and slow evolution rate revealed by in vivo infection.

Authors:  Bernadette Schmid; Christine Rösler; Michael Nassal
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

7.  Critical role of the 36-nucleotide insertion in hepatitis B virus genotype G in core protein expression, genome replication, and virion secretion.

Authors:  Ke Li; Fabien Zoulim; Christian Pichoud; Karen Kwei; Stéphanie Villet; Jack Wands; Jisu Li; Shuping Tong
Journal:  J Virol       Date:  2007-06-13       Impact factor: 5.103

8.  Hepatitis B virus molecular biology and pathogenesis.

Authors:  R Jason Lamontagne; Sumedha Bagga; Michael J Bouchard
Journal:  Hepatoma Res       Date:  2016-07-01

9.  Separate origins of hepatitis B virus surface antigen-negative foci and hepatocellular carcinomas in transgenic HBsAg (alb/psx) mice.

Authors:  Dana R Crawford; Stephanie Ostrowski; Dilip Vakharia; Zoran Ilic; Stewart Sell
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

10.  Effect of viral load on T-lymphocyte failure in patients with chronic hepatitis B.

Authors:  Jing You; Hutcha Sriplung; Alan Geater; Virasakdi Chongsuvivatwong; Lin Zhuang; Hong-Ying Chen; Lan Yu; Bao-Zhang Tang; Jun-Hua Huang
Journal:  World J Gastroenterol       Date:  2008-02-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.